Breaking News

TruTag Technologies’ Manufacturing Plant Achieves GMP Compliance

Nano-porous silica manufacturing facility will produce TruTag microtags for global pharmaceutical customers

TruTag Technologies’ silica microtag manufacturing facility in Kapolei, Hawaii has achieved compliance with current Good Manufacturing Practices (cGMP) for the manufacturing of TruTag microtags (TruTags) to protect pharmaceutical and food products for global manufacturers and brand owners.

TruTags are covert, edible, and encrypted optical memory devices made from pure silicon dioxide (silica), a material that is considered “generally recognized as safe” (GRAS) by the U.S. FDA. TruTags enable the digitization of medicine and food so that customers can identify, authenticate, and track products throughout the global supply chain. TruTags serve as a digital cookie for analog products.

TruTag says its security platform helps pharmaceutical and food companies protect their products, guard against channel diversion and counterfeits, enhance consumer trust, retrieve valuable information real time, and maintain the integrity of their brands with cost-effective integrated data intelligence. When TruTags are applied to products, manufacturers are able to assess the provenance of each item and collect information such as manufacturing site, dosage, authorized distribution channel, lot numbers, and other information including the entire drug package insert or related safety information, if needed.

According to the company, its manufacturing facility is the world’s largest cGMP nano-porous silica production plant and houses the company’s application engineering and advanced materials research center. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters